Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | COL6A3 |
| Upstream (Parents) |
|---|
| (<<) COL5A1 → COL6A3 |
| (<<) COL5A2 → COL6A3 |
| Downstream (Children) |
|---|
| COL6A3 → CES4 (>>) |
| COL6A3 → PMP22 (>>) |
| COL6A3 → EMILIN1 (>>) |
| COL6A3 → MXRA7 (>>) |
| COL6A3 → CSGALNACT1 (>>) |
| COL6A3 → COL10A1 (>>) |
| COL6A3 → PDPN (>>) |
| COL6A3 → EHD2 (>>) |
| COL6A3 → PRR16 (>>) |
| COL6A3 → HBD (>>) |
| COL6A3 → MMP14 (>>) |
| COL6A3 → LGALS1 (>>) |
| COL6A3 → COL5A2 (>>) |
| COL6A3 → EGR3 (>>) |
| COL6A3 → LAMC1 (>>) |
